Anavex Life Sciences Corp.

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

20,345

Value ($000)

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	72	0.0%	20,345	12/31/2025
2025 Q3	11/14/2025	181	0.0%	20,345	9/30/2025
2025 Q2	8/13/2025	188	0.0%	20,345	6/30/2025
2025 Q1	5/12/2025	175	0.0%	20,345	3/31/2025
2024 Q4	2/10/2025	219	0.0%	20,345	12/31/2024
2024 Q3	11/8/2024	116	0.0%	20,345	9/30/2024
2024 Q2	8/8/2024	86	0.0%	20,345	6/30/2024
2024 Q1	5/8/2024	157	0.0%	18,295	3/31/2024
2023 Q4	2/9/2024	189	0.0%	20,345	12/31/2023
2023 Q3	11/8/2023	133	0.0%	20,345	9/30/2023
2023 Q2	8/11/2023	162	0.0%	19,935	6/30/2023
2023 Q1	6/14/2023	157	0.0%	18,295	3/31/2023
2022 Q4	6/14/2023	169	0.0%	18,295	12/31/2022
2022 Q3	11/8/2022	185	0.0%	17,895	9/30/2022
2022 Q2	8/5/2022	179	0.0%	17,895	6/30/2022
2022 Q1	5/6/2022	220	0.0%	17,885	3/31/2022
2021 Q4	2/8/2022	310	0.0%	17,885	12/31/2021
2021 Q3	11/8/2021	302	0.0%	16,841	9/30/2021
2021 Q2	8/10/2021	657	0.0%	28,759	6/30/2021
2021 Q1	5/10/2021	162	0.0%	10,858	3/31/2021
2020 Q4	2/8/2021	59	0.0%	10,858	12/31/2020
2020 Q3	11/9/2020	49	0.0%	10,858	9/30/2020
2020 Q2	8/7/2020	53	0.0%	10,858	6/30/2020